ed J Australia 1:426-8, 1983.
6.Jones RB, et al. Safe handling of chemotherapeutic agents: A report from the Mount Sinai Medical Center. CA: A Cancer Journal for Clinicians 33:258-63, 1983.
7.American Society of Hospital Pharmacists technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm 47:1033-49, 1990.
Hospira, Inc.
Lake Forest, IL 60045
Product of Australia
Revised: April 2009
431508
431511
Nipent
pentostatin injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0409-0801
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PENTOSTATIN (Pentostatin) PENTOSTATIN 2 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
MANNITOL
SODIUM HYDROXIDE
HYDROCHLORIC ACID
Packaging
Item Code Package Description
1 NDC:0409-0801-01 1 VIAL, SINGLE-DOSE (1 VIAL) in 1 CARTON
1 5 mL in 1.0 VIAL, SINGLE-DOSE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020122 11/02/2009
Labeler - Hospira, Inc. (141588017)
